| 标题 |
[高分]
 专利、报告等 A Phase 1/2, First-in-Human, Open-Label, Dose-Escalation and Expansion Study of IMGC936 (Anti-ADAM9 Antibody Drug Conjugate) in Patients With Advanced Solid Tumors IMGC936（抗ADAM9抗体药物缀合物）在晚期实体瘤患者中的1/2期、首次人体、开放标记、剂量递增和扩增研究
|
| 网址 | |
| DOI |
暂未提供，该求助的时间将会延长，查看原因？
|
| 其它 |
IndicationsAdvanced breast cancer; Colorectal cancer; Gastric cancer; Male breast cancer; Non-small cell lung cancer; Oesophageal cancer; Pancreatic cancer; Solid tumours; Triple negative breast cancer FocusAdverse reactions; First in man; Therapeutic Use |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时，文件已从服务器自动删除，无法下载。 |
我是站长才怪
爱静静
带头大哥
劲秉
美好乐松
HEIKU
彭于彦祖
Billy
司南
tuanheqi
秀丽烨霖
yangguang2000
搜集达人
shinysparrow
寻道图强
田様
mhl11
lilivite
平常的毛豆
领导范儿
皖公网安备34019202002308
